Detalles de la búsqueda
1.
Biochemometric Analysis of Fatty Acid Amide Hydrolase Inhibition by Echinacea Root Extracts.
Planta Med
; 87(4): 294-304, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33296937
2.
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.
N Engl J Med
; 375(6): 545-55, 2016 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27509102
3.
Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α.
Mol Ther
; 25(5): 1199-1208, 2017 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28341561
4.
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.
J Med Genet
; 54(4): 288-296, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27834756
5.
Evaluation of the safety, pharmacodynamic, and pharmacokinetic effects following oral coadministration of immediate-release morphine with ethanol in healthy male participants.
Hum Psychopharmacol
; 29(3): 251-65, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24911576
6.
Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02).
J Neurol
; 271(4): 1787-1801, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38057636
7.
Population Pharmacokinetics of Oral Migalastat in Adolescents and Adults With and Without Renal Impairment.
Clin Pharmacol Drug Dev
; 11(12): 1367-1381, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36331497
8.
The relative bioavailability of morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®) and an extended release morphine sulfate capsule formulation (KADIAN®) in healthy adults under fasting conditions.
Am J Ther
; 18(1): 2-8, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20864883
9.
Migalastat Tissue Distribution: Extrapolation From Mice to Humans Using Pharmacokinetic Modeling and Comparison With Agalsidase Beta Tissue Distribution in Mice.
Clin Pharmacol Drug Dev
; 10(9): 1075-1088, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33876577
10.
Spontaneous tension pneumothorax and acute pulmonary emboli in a patient with COVID-19 infection.
BMJ Case Rep
; 13(8)2020 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32784238
11.
Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-controlled, crossover study.
Clin Drug Investig
; 29(12): 777-90, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19888784
12.
Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders.
Orphanet J Rare Dis
; 14(1): 36, 2019 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30736861
13.
Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsules.
J Pain
; 9(4): 330-6, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18201934
14.
Transcriptome changes in apple peel tissues during CO2 injury symptom development under controlled atmosphere storage regimens.
Hortic Res
; 2: 15061, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-27087982
15.
Relative bioavailability and the effect of meal type and timing on the pharmacokinetics of migalastat in healthy volunteers.
Clin Pharmacol Drug Dev
; 4(3): 193-202, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-27140799
16.
An open-label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function.
Clin Pharmacol Drug Dev
; 4(4): 256-61, 2015 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27136905
17.
Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase.
PLoS One
; 10(8): e0134341, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26252393
18.
Pharmacokinetics and pharmacodynamics of a novel nizatidine controlled-release formulation in healthy subjects.
J Clin Pharmacol
; 43(1): 74-83, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12520631
19.
The bioequivalence of nizatidine (Axid) in two extemporaneously and one commercially prepared oral liquid formulations compared with capsule.
J Clin Pharmacol
; 43(2): 148-53, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12616667
20.
Single-dose pharmacokinetics of nizatidine (Axid) in children.
J Clin Pharmacol
; 42(10): 1089-96, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12362922